Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Bulgaria Croatia Denmark Estonia France +5
  • Study on the Safety and Effectiveness of BCN-CP01 for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    2 1 1
    Belgium The Netherlands Spain
  • Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark France Greece Ireland Poland +1
  • Study on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    France Greece Spain